Aizawa Takuya, Maebayashi Toshiya, Ishibashi Naoya, Sakaguchi Masakuni, Sato Akahiko, Yamaguchi Kenya
Department of Radiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, 173-8610, Japan.
Department of Radiology, Nihon University Hospital, Chiyoda-ku, Tokyo, 101- 8309, Japan.
BMC Urol. 2023 Oct 4;23(1):157. doi: 10.1186/s12894-023-01323-5.
Administration of adjuvant or salvage radiotherapy (RT) after prostate cancer (PCa) surgery is supported by clinical evidence and is a widely adopted strategy. On occasion, we detect changes in prostate-specific antigen (PSA) levels, such as a transient elevation or decline, during RT. Thus, we retrospectively investigated the frequency of changes in PSA levels, their associations with histopathological parameters, PSA doubling time (PSADT), and biochemical recurrence (BR) of PCa.
This study included 23 consecutive patients who underwent surgery for PCa between 2012 and 2019, received salvage RT without hormone therapy, and exhibited changes in PSA levels during RT. The prostatic bed was irradiated with a total dose of 64 to 66 Gy. BR was defined as consecutive PSA levels exceeding 0.2 ng/mL or having to start hormone therapy because of PSA elevation after salvage RT.
During salvage RT after PCa surgery, PSA levels transiently increased in 11 patients (47.8%) and decreased in 12 (52.2%). When factors associated with BR were examined in patients with transient PSA elevation, seminal vesicle invasion and preoperative PSA values were identified as being statistically significant. When factors for BR were examined in patients with a decline in PSA levels, the Gleason score and PSADT were identified as being significant. Among the cases of a decline in PSA levels during salvage RT, those who received a radiation dose of less than 36 Gy did not experience BR. Similarly, patients who exhibited changes in PSA levels during salvage RT and did not have perineural invasion did not experience BR.
This is the first study to examine the histopathological factors possibly affecting BR in patients undergoing salvage RT after PCa surgery. The results indicate that in patients with transient PSA elevation, seminal vesicle invasion is a significant risk factor. On the other hand, in patients with a decline in PSA levels during irradiation, the Gleason score and perineural invasion were found to be potential risk factors for BR. These findings suggest that a thorough examination of postoperative histopathological results may be necessary for the optimal management of patients with PCa.
前列腺癌(PCa)手术后辅助或挽救性放疗(RT)的应用有临床证据支持,是一种广泛采用的策略。有时,我们在放疗期间检测到前列腺特异性抗原(PSA)水平的变化,如短暂升高或下降。因此,我们回顾性研究了PSA水平变化的频率、它们与组织病理学参数、PSA倍增时间(PSADT)以及PCa生化复发(BR)的相关性。
本研究纳入了2012年至2019年间连续23例接受PCa手术、接受无激素治疗的挽救性放疗且在放疗期间PSA水平有变化的患者。前列腺床接受的总剂量为64至66 Gy。BR定义为挽救性放疗后连续PSA水平超过0.2 ng/mL或因PSA升高而必须开始激素治疗。
在PCa手术后的挽救性放疗期间,11例患者(47.8%)的PSA水平短暂升高,12例(52.2%)下降。在PSA短暂升高的患者中检查与BR相关的因素时,精囊侵犯和术前PSA值具有统计学意义。在PSA水平下降的患者中检查BR相关因素时,Gleason评分和PSADT具有显著意义。在挽救性放疗期间PSA水平下降的病例中,接受辐射剂量小于36 Gy的患者未发生BR。同样,在挽救性放疗期间PSA水平有变化且无神经周围侵犯的患者未发生BR。
这是第一项研究PCa手术后接受挽救性放疗患者中可能影响BR的组织病理学因素的研究。结果表明,在PSA短暂升高的患者中,精囊侵犯是一个重要的危险因素。另一方面,在放疗期间PSA水平下降的患者中,Gleason评分和神经周围侵犯被发现是BR的潜在危险因素。这些发现表明,对PCa患者进行最佳管理可能需要对术后组织病理学结果进行全面检查。